Literature DB >> 12883262

Pancreatic cancer mortality in Europe: the leveling of an epidemic.

Fabio Levi1, Franca Lucchini, Eva Negri, Carlo La Vecchia.   

Abstract

Mortality rates from pancreatic cancer have increased throughout Europe between the late 1950s and the 1980s. Trends in 22 European countries, the European Union (EU) and 6 selected eastern European countries have been updated using official death certification data for pancreatic cancer abstracted from the WHO database over the period 1980 to 1999. In EU men, a rise from 7.2 to 7.5/100,000 was observed between the early and the late 1980s, followed by a leveling off in the 1990s. For women, rates tended to rise up to the early 1990s, and to level off thereafter around 4.7/100,000. In eastern countries, rates for both sexes rose between the early 1980s and the mid-1990s, and leveled off thereafter around 8.5/100,000 men and 5/100,000 women. Thus, rates for men only were higher in Eastern Europe than in the EU. This analysis first documents a leveling of pancreatic cancer mortality in Europe, after decades of steady rises. This is partly or largely attributable to the decline in smoking, at least in men, but other factors, including mainly nutrition and diet, may also have played some role on these trends.

Entities:  

Mesh:

Year:  2003        PMID: 12883262     DOI: 10.1097/00006676-200308000-00006

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  14 in total

1.  Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer.

Authors:  Xiaohui Duan; Langmei Deng; Xiong Chen; Yebin Lu; Qi Zhang; Kejing Zhang; Yongjun Hu; Jie Zeng; Weijia Sun
Journal:  Med Oncol       Date:  2010-03-31       Impact factor: 3.064

2.  A geographic correlation study of the incidence of pancreatic and other cancers in Whites.

Authors:  Paolo Boffetta; Marine Castaing; Paul Brennan
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

3.  Analysis of mortality rates for pancreatic cancer across the world.

Authors:  D Hariharan; A Saied; H M Kocher
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

4.  Cancer mortality among men in Central Serbia: 1985-2006 survey study.

Authors:  Ljiljana Marković-Denić; Hristina Vlajinac; Snezana Zivković; Dragan Miljus
Journal:  Croat Med J       Date:  2008-12       Impact factor: 1.351

5.  High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF.

Authors:  Andreas-Claudius Hoffmann; Ryutaro Mori; Daniel Vallbohmer; Jan Brabender; Uta Drebber; Stephan E Baldus; Ellen Klein; Mizutomo Azuma; Ralf Metzger; Christina Hoffmann; Arnulf H Hoelscher; Kathleen D Danenberg; Klaus L Prenzel; Peter V Danenberg
Journal:  J Gastrointest Surg       Date:  2008-08-13       Impact factor: 3.452

6.  High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.

Authors:  Andreas-Claudius Hoffmann; Ryutaro Mori; Daniel Vallbohmer; Jan Brabender; Ellen Klein; Uta Drebber; Stephan E Baldus; Janine Cooc; Mizutomo Azuma; Ralf Metzger; Arnulf H Hoelscher; Kathleen D Danenberg; Klaus L Prenzel; Peter V Danenberg
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

Review 7.  Cigarette smoke-induced pancreatic damage: experimental data.

Authors:  Uwe A Wittel; Ulrich T Hopt; Surinder K Batra
Journal:  Langenbecks Arch Surg       Date:  2008-01-12       Impact factor: 3.445

8.  Exocrine pancreatic carcinogenesis and autotaxin expression.

Authors:  Sandeep Kadekar; Ilona Silins; Anna Korhonen; Kristian Dreij; Lauy Al-Anati; Johan Högberg; Ulla Stenius
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

9.  Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancer.

Authors:  Juraj Hlavaty; Helga Petznek; Harry Holzmüller; Angelika Url; Gerrit Jandl; André Berger; Brian Salmons; Walter H Günzburg; Matthias Renner
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

Review 10.  A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.

Authors:  A Carrato; A Falcone; M Ducreux; J W Valle; A Parnaby; K Djazouli; K Alnwick-Allu; A Hutchings; C Palaska; I Parthenaki
Journal:  J Gastrointest Cancer       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.